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Two cDNA clones for human placental aromatase P-450 (P-450 AROM) have been isolated and sequenced. The insert of 
one clone (2894 bp) contains an open reading frame encoding a protein consisting of 503 amino acid residues together 
with a 49 bp S-untranslated stretch and a 1336 bp 3’-noncoding region to which a poly(A) tract is attached. Three poten- 
tial poly(A) addition signals are detected in this 3’noncoding region. The other clone contains a shorter cDNA insert, 
the nucleotide sequence of which overlaps with most of the sequence of the longer cDNA insert (nucleotides 36-2355) 
except for one nucleotide substitution. The 3’noncoding region of this shorter cDNA is only 846 bp in length, but a 
poly(A) tract is also attached to its 3’-terminus. Northern blot analysis of human placental RNA reveals the presence 
of two major mRNA species of 3.4 and 2.9 kb when probes excised from the overlapping region of these two cDNAs 
are employed. The 2.9 kb mRNA is not detected, however, when a fragment of the non-overlapping region of the longer 
cDNA is used as a probe. It is therefore concluded that the two major species of P-4SOAROM mRNA are formed as a 
consequence of alternative processing of precursor mRNA(s). 
Monooxygenase; Aromatase P-450; Estrogen synthesis; cDNA; Poly(A) addition signal; (Human placenta) 
1. INTRODUCTION 
The conversion of androgens to estrogens is 
catalyzed by a specific monooxygenase [I], called 
aromatase P-450 (P-450AROM) Or estrogen Syn- 
thetase [2-41. The mechanism Of P-45OARoM ex- 
pression has received much attention, because 
various androgens are converted to different 
species of estrogen in a tissue-specific fashion [5-71 
and the ‘P-450AROM expression is regulated by a 
variety of factors such as cyclic AMP, glucocor- 
ticoids and growth factors [8]. 
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The nucleotide sequence presented here has been submitted to 
the EMBL/GenBank database under the accession no. YO7508 
Based on the tissue-specific synthesis of different 
estrogens, Osawa et al. [9] have suggested the ex- 
istence of two or more forms of P+oAROM differ- 
ing in substrate specificities. Recent cloning and se- 
quencing of partial-length cDNAs for human 
P-450AROM have led t0 the SUggeStiOn that there ex- 
ist three different P-450ARoM mRNAs [lo] or at 
least two P-450AROM genes [ll]. More recently, 
full-length cDNAs for P-45OAROM have been 
isolated from chicken ovarial [12] and human 
placental [13,14] cDNA libraries and sequenced. 
As a first step to investigate strogen-dependent 
diseases in humans, we here report the isolation 
and Sequencing Of tW0 P-450AROM CDNA ClOneS 
derived from human placenta. The results provide 
evidence that the occurrence of two major species 
of mRNA for P-450AROM is mainly ascribed to the 
alternative RNA processing using different poly(A) 
addition signals. 
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2. MATERIALS AND METHODS 
2.1. Materials 
The oligo(dT)-primed human placental cDNA library con- 
structed in hgtll from poly(A)+ RNA [15] was kindly supplied 
by Dr Y. Ebina, University of Tokushima. Two oligonucleotide 
probes (44-mer, 5’-AC! CAC CAG CAT CAG GTA GTG GAT 
GGG GTT CAG CAT CTC CAG CAC-3 ‘; 35mer, 5 ‘-TT CTG 
GAT GCT CTC CAC ACA CTG GCC CTG CAG GGT-3’) 
were synthesized by the modified triester method [16]. The base 
sequences of both probes were designed on the basis of partial 
amino acid sequences of human placental P‘45OAaoM [17], using 
published data for codon usage frequencies [18]. All other 
materials including restriction endonucleases, [c+32P]dCTP and 
[y-‘*P]ATP were obtained from commercial sources. 
2.2. Cloning procedures 
The cDNA library on E. coli Y1088 was screened by 
hybridization with the 32P-labeled oligonucleotide probes. 
Nitrocellulose filters containing plaque replicas were hybridized 
at 38°C with the 35-mer probe for at least 14 h in 3 x SSC, 10 x 
Denhardt’s solution containing denatured herring DNA 
(100 pg/ml). With the 44-mer as probe, hybridization was per- 
formed at 40°C. The filters were washed at the same 
1 500 1000 1500 
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temperature as that used for hybridization for 20 min with 6 x 
SSC containing 0.1% SDS, and then with 3 x SSC containing 
0.1% SDS. They were further washed at 55°C for 10 min with 
3 x SSC containing 0.1% SDS. 
2.3. Nucleotide sequencing 
The cDNAs were digested with appropriate restriction endo- 
nucleases and the fragments were subcloned into Ml3mpl8 or 
19 [19]. Nucleotide sequencing was conducted by the dideoxy 
chain-termination method [20] according to the strategy shown 
in fig.!. 
2.4. Northern blot analysis 
Total RNA was extracted from human placenta as described 
by Chirgwin et al. [21]. Poly(A)+ RNA was enriched therefrom 
by oligo(dT)-cellulose chromatography [22]. Total RNA (20 fig) 
or poly(A)+ RNA (4pg) was subjected to agarose gel electro- 
phoresis and transferred to nitrocellulose filters [23,24]. 
Hybridization was carried out using “P-labeled probes (probes 
A-C in fig.!). The DNA size markers used were fragments of 
pUCll9 DNA cut with DraI (2454 bp), PvuII (2840 bp) or Hin- 
dIII(3162 pb) and linearized plasmid DNA (4009 bp) consisting 
of pUCl18 DNA (3162 bp) and the EcoRI-KpnI fragment of 
pES-1 (847 bp). 
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Fig. 1. Restriction map of and sequencing strategy for the cloned cDNAs encoding human placental P-45OAaoM. The restriction map 
displays only relevant restriction endonuclease sites with numbers which indicate the 5’-terminal nucleotide position generated by 
cleavage (for nucleotide numbering, see fig.2). The protein coding region is indicated by a closed box. The hatched boxes represent the 
restriction fragments of the cDNA inserts employed as hybridization probes for the experiments in fig.3: (A) EcoRI(247)-XhoI(l210) 
fragment; (B) ScaI(l971)-AluI(2368) fragment; (C) AfuI(2431)-EcoRI(2709J fragment. The direction and the extent of sequence deter- 
minations are indicated by horizontal arrows under each cDNA insert. 
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1 10 20 30 40 
MetValLeuGluMetLeuAsnProIleHisTyrAsnIleThrSerIleValProGluAlaMetProAlaAlaThrMetProValLeuLeuLeuThrGlyLeuPheLeuLeuValTrpAsn 
ATGGTTTTGGAAATGCTGAACCCGATACATTATAA TCACCAGCATCGTGCCTGAAGCCATGCCTGCTGCCACCATGCCAGTCCTGCTCCTCACTGGCCTTTTTCTCTTGGTGTGGAAT 
kd 
50 ’ 60 70 80 
TyrGluGlyThrSerSerIleProGlyProGlyTyrCysMetGlyIleGlyProLeuIleSerHisGlyArgPheLeuTrpMetGlyIleGlySerAlaCysAsnTyrTyrAsnArgVal 
TATGAGGGCACATCCTCAATACCAGGTCCTGGCTACTGCATGGGAATTGGACCCCTCATCTCCCACGGCAGATTCCTGTGGATGGGGATCGGCAGTGCCTGCAACTACTACAACCGGGTA 
go 100 110 120 
TyrGlyGluPheMetArgValTrpIleSerGlyGluGluThrLeuIleIleSerLysSerSerSerMetPheHisIleMetLysHisAsnHisTyrSerSerArgPheGlySerLysLeu 
TATGGAGAATTCATGCGAGTCTGGATCTCTGGAGAGGAAACACTCATTATCAGCAAGTCCTCAAGTATGTTCCACATAATGAAGCACAATCATTACAGCTCTCGATTCGGCAGCAAACTT 
130 140 150 160 
GlyLeuGlnCysI1eGlyMetHisGluLysGlyIleIlePheAsnAsnAsnProGluLeuTrpLysThrThrArgProPhePheMetLysAlaLeuSerGlyProGlyLeuValArgMet 
GGGCTGCAGTGCATCGGTATGCdTGAGdAAGGCATCATATTTAACAACAATCCAGAGCTCTGGA~dCAACTCGACCCTTCTTTATGAAAGCTCTGTCAGGCCCCGGCCTTGTTCGTATG 
170 180 190 200 
ValThrValCysAlaGluSerLeuLysThrHisLeuAspArgLeuGluG1uValThrAsnGluSerGlyTyrValAspValLeuThrLeuLeuArgArgVa1MetLeuAspThrSerAsn 
GTCACAGTCTGTGCTGAATCCCTCAAAACACATCTGGACAGGTTGGAGGAGGTGACCAATGAATCGGGCTATGTGGACGTGTTGACCCTTCTGCGTCGTGTCATGCTGGACACCTCTAAC 
210 220 230 240 
ThrLeuPheLeuArgIleProLeuAspGluSerAlaIleValValLysIleGlnGlyTyrPheAspAlaTrpGlnAlaLeuLeuIleLysProAspIlePhePheLysIleSerTrpLeu 
ACGCTCTTCTTGAGGATCCCTTTGGACGAAAGTGCTATCGTGGTTA~ATCCAAGGTTATTTTGATGCATGGCAAGCTCTCCTCATCAAACCAGACATCTTCTTTAAGATTTCTTGGCTA 
250 260 270 280 
TyrLysLysTyrGluLysSerValLysAspLeuLysAspAlaIleGluValLeuI1eAlaGluLysArgArgArgIleSerThrGluG1uLysLeuGluGluCysMetAspPheAlaThr 
TACAAAAAGTATGAGAAGTCTGTCAAGGATTTGAAAGATGCCATAG~GTTCTGATAGCAGAAAAAAGACGCAGGATTTCCACAG~GAGA~CTGG~GAATGTdTGGACTTTGCCACT 
290 300 310 320 
GluLeuIleLeuAlaGluLysArgGlyAspLeuThrArgGluAsnValAsnGlnCysIleLeuGluMetLeuIleAlaAlaProAspThrMetSerValSerLeuPhePheMetLeuPhe 
GAGTTGATTTTAGCAGAGACGTGGTGACCTGACAAGAGAGAATGTG~CCAGTGCATATTGGAAATGCTGATCGCAGCTCCTGACACCATGTCTGTCTCTTTGTTCTTCATGCTATTT 
330 340 350 360 
LeuIleAlaLysHisProAsnValGluGluAlaIleIleLysGluIleGlnThrValIleGlyGluArgAspIleLysIleAspAspIleGlnLysLeuLysValMetGluAsnPheIle 
CTCATTGCAAAGCACCCTAATGTTGAAGAGGCAATAATAAAGG~ATCCAGACTGTTATTGGTGAGAGAGACATAAAGATTGATGATATACAAAAATTAAAAGTGATGGAAAACTTCATT 
370 380 390 400 
TyrGluSerMetArgTyrGlnProValValAspLeuValMetArgLysAlaLeuGluAspAspValIleAspGlyTyrProValLysLysGlyThrAsnIleIleLeuAsnIleGlyArg 
TATGAGAGCATGCGGTACCAGCCTGTCGTGGACTTGGTCATGCGC~AGCCTTAGAAGATGATGTAATCGATGGCTACCCAGTGA~AAGGGGACAAACATTATCCTG~TATTGGAAGG 
410 420 430 440 
MetHisArgLeuGluPhePheProLysProAsnGluPheThrLeuGluAsnPheAlaLysAsnVa1ProTyrArgTyrPheGlnProPheGlyPheGlyProArgGlyCysAlaGlyLys 
ATGCACAGACTCGAGTTTTTCCCCAAACCCAATGAATTTACTCTTG~AATTTTGCAAAG~TGTTCCTTATAGGTACTTTCAGCCATTTGGCTTTGGGCCCCGTGGCTGTGCAGGAAAG 
450 460 470 480 
TyrIleAlaMetValMetMetLysAlaIleLeuValThrLeuLeuArgArgPheHisValLysThrLeuGlnGlyGlnCysValGluSerIleGlnLysIleHisAspLeuSerLeuHis 
TACATCGCCATGGTGATGATGAAAGCCATCCTCGTTACACTTCTGAGACGATTCCACGTGAAGACATTGCAAGGACAGTGTGTTGAGAGCATACAGAAGATACACGACTTGTCCTTGCAC 
490 500 
ProAspGluThrLysdsnMetLeuGluMetIlePheThrProArgdsnSerAspArgCysLeuGluHis~ 
CCAGATGAGACTAAAAACATGCTGGAAATGATCTTTACCCCAAG~ACTCAGACAGGTGTCTGGAACACTAGAGAAGGCTGGTCAGTACCTACTCTGGAGCATTTCTCATCAGTAGTTCA 
CATACAAATCATCCATCCTTGCCAATAGTGTCATCCTCACAGTG~CACTCAGTGGCCCATGGCATTTTATAGGCATACCTCCTATGGGTTGTCACCAAGCTAGGTGCTATTGGTCATCT 
GCTCCTGTTCACACCAGAGAACCAGGCTACAAGAGAAAAAGCAGAGGCCAAGAGTTTGAGGGAGA~TAGTCGGTGAAG~CCGTATCCATAAAGACCCGATTCCACCA~TGTGCTTT 
GAGAAGGATAGGCCTTCATTAACAAAATGTATGTCTGGTTCCCCAGTAGAGCTCTACTGCCTCAACCCAAGGGGATTTTTATGTCTGGGGCAGAAACACTCAAGTTGATTAGAAAGACCA 
GGCCAATGTCAGGGTACCTGGGGCCAAACCCACCTGCTAGTGTG~~GTACTTTAATTTTGTTTTCTGTGGAGGTGG~AAGCAACATTCATAGTCTTTGGAG~ATGCTTAGAAA 
TTCAGCATTTGACCCTTGCTGTGAATTAAGCCCAATTAAiTGATCTGTCTGTGGCAAAAGTTTAATCAGAGGAAATTCTTTCCCAGTCTGTCGATTTATGCCT 
CAGCCACTTGCCTGTGCTACAATTCATTGTGTTACCTGTAGATTCAGGTAATACAAACTATATAT~TCATC~GTAATACAAACTAATTTAGTAATAGCCTGGGTTAAGTATTATTAGG 
GCCCTGTGTCTGCTGTAGAAAAAAATTCACATGATGCACTTCAAATTCAAATA~~TCCTTTTGGCATGTT CATTTTTGCTTAGCTCAATTAGTGTGGCTAACCAAGAGATAACT 
Y 
GTAAATGTGACATTGATTTGCTCTTACTACAGCTTCAGTGATTGGGGGAGGAA~GTCCCAACCCAATGGGCTCAAACTTCTAAGGGGTACTCCTCTCATCCCCTTATCCTTCTCCCTCG 
ACATTTTCTCCCTCTTTCTTCCCATGACCCCAAAGCCAAGGGCAACAGATCAGTAAAGAACGTGGTCAGAGTAGAACCCCTGAAGTATTTTTTAATCCTACCTCAAAATTTAACAGTTAC 
CTGAGAGATTTAACATTATCTAGTTCATTGAATCATTGTATGTGGTCATGGATAAATTGCACACCTTGG~TTCGCTTTCTA~GGA~TCAAATGAATGGAGGAACTTTCCAAACACCA 
CTTTACTTGTGTTATATAGCCAATAldACTATCTCTACTGAATGTCATTGAAA~CT~AAA~CTTATTTAC~ATAGGTAAA~AAAAAAA~AA~AAA-------------3 
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Fig.2. Nucleotide sequence of the cloned pES-1 cDNA encoding P-450 AROM. Nucleotides are numbered in the 5 ’ to 3 ’ direction, and 
nucleotides upstream of the first nucleotide of the translational initiation codon ATG (Met) are indicated by negative numbers. The star 
symbols upstream and downstream of the protein coding region indicate the stop codons. The sequences underlined in the 3 ‘-noncoding 
region represent potential poly(A) addition signals. The sequence between nucleotides 36 and 2355 as divided by two vertical arrows 
overlaps completely with pES-1 and pES-2 except that ACC (Thr, amino acid residue 14) in pES-1 is substituted with TCC (Ser) in 
pES-2. For details, see text. Also, in pES-2, the poly(A) tract is attached to the nucleotide C at nucleotide 2355 as sh&n above. 
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3. RESULTS 
Screening of the human placental cDNA library 
in hgtll (- 5 x lo4 plaques) with the 35mer probe 
resulted in the detection of about 200 positive 
clones. Characterization of 5 randomly chosen 
clones indicated that one clone contained a 2.4 kbp 
insert that resembled those reported by Simpson et 
al. [lo] and Chen et al. [ll]. Upon rescreening of 
the same library with an EcoRI-BamHI fragment 
of the 2.4 kbp insert as a probe, 198 positive clones 
were obtained. Of these, 23 clones were randomly 
isolated and selected with the 44-mer synthetic 
probe. It was thus possible to isolate two cDNA 
clones, pES-1 and pES-2, containing 2.9 and 
2.3 kbp inserts, respectively. 
kb 
12 12 12 
Fig.3. Autoradiograms of blot hybridization analysis of human 
placental RNA. Total RNA (1) or poly(A)+ RNA (2) was 
hybridized with probes A-C as described in the legend to fig. 1. 
The horizontal arrows with numerals indicate the position of 
nucleotide size markers (see section 2). 
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Fig.1 shows the restriction map and sequencing 
strategy for the two cDNAs cloned. The nucleotide 
sequence determined for the pES-1 insert, which 
consists of 2894 bp (excluding the poly(A) tract), is 
presented in fig.2. The translation initiation site of 
pES-1 cDNA can be assigned as the methionine 
codon at nucleotides l-3, because this is the first 
ATG codon appearing downstream of the stop 
codon TAA (nucleotides - 33 to - 3 1) that is in- 
frame with the largest open reading frame. This is 
also supported by the fact that the sequence around 
the ATG triplet agrees well with the favored se- 
quence that flanks the functional initiation codon: 
i$XXAUGG, where X is any nucleotide [25]. The 
open reading frame starting from this initiation 
codon consists of 1509 nucleotides (encoding a 
polypeptide of 503 amino acid residues) followed 
by the stop codon TAG (nucleotides 1510-1512). A
poly(A) tract is attached to the 3 ‘-terminus of the 
1336 bp 3 ‘-noncoding region of this cDNA. On the 
other hand, the cDNA insert of pES-2 is shorter 
(2320 bp) and corresponds to the segment of pES-1 
cDNA from nucleotides 36 to 2355 (see legend to 
fig.2). The two nucleotide sequences are identical 
with each other except for a single base substitution 
(A+T) at nucleotide 40 in pES-2 cDNA. An im- 
portant finding is that a poly(A) tract is also at- 
tached to the 3 ‘-terminus of pES-2 cDNA, even 
though its 3 ‘-noncoding region is only 846 bp in 
length. Moreover, three potential poly(A) addition 
signals (underlined in fig.2) can be detected in the 
3 ‘-noncoding region of pES-1 cDNA, but the third 
signal is lacking in pES-2 cDNA. The primary 
structure of the polypeptide deduced from the 
cDNA sequence is also shown in fig.2. 
To determine the size of mRNA(s) encoding 
E-45OAROM, total RNA and pOiy(A)+ RNA from 
human placenta were analyzed by Northern blot 
hybridization using probes A-C, which had been 
cut out of pES-1 cDNA (see fig-l). When probe A 
or B was used, two major mRNA bands of 3.4 and 
2.9 kb were detected (fig.3). The 2.9 kb mRNA 
was not detected, however, when a fragment of the 
non-overlapping region of pES-1 cDNA (probe C) 
was used. These results indicate that pES-1 and 
pES-2 cDNAs are derived from the 3.4 and 2.9 kb 
mRNAs, respectively, and that these two major 
SpeCieS Of P-450AROM mRNA are formed as a con- 
sequence of alternative RNA processing using two 
different poly(A) addition signals. 
Volume 247, number 2 FEBS LETTERS April 1989 
4. DISCUSSION 
A comparison of the nucleotide sequences of 
pES-1 and pES-2 cDNAs with those of human 
P-450A~o~ cDNAs as determined by other workers 
[lo, 11,13,14] indicates that all the sequences are 
very similar to one another in the protein coding 
region; changes detectable are substitutions of at 
most 2 nucleotides. However, nucleotide substitu- 
tions, deletions and additions are more marked (up 
to 14 nucleotides) in the 3’-noncoding region of the 
cDNAs (Toda, K., unpublished). The minor dif- 
ferences in the coding region are probably due to 
allelic variants, but the reason for significant 
changes in the 3 ‘-noncoding region is unclear. 
Evans et al. [26] reported the occurrence of three 
mRNAs (3.0, 2.7 and 2.4 kb) for human placental 
P-450ARoM. They dS0 isolated tW0 P-&&ROM 
cDNAs of different length and suggested that the 
two major mRNAs are formed by differential 
RNA processing [lo]. Chen et al. [ 1 l] also reported 
a partial sequence of human P-45OAROM CDNA and 
mapped the corresponding gene on chromosome 
15. They further suggested the possibility that there 
exist at least two different P-45OAROM genes and 
that the two major mRNAs in human placenta are 
probably derived from the different genes. More 
recently, Harada [14] has suggested that different 
transcription initiation or alternative splicing of the 
5 ‘-untranslated region of precursor mRNA is 
responsible for the formation of two major species 
of P-450AROM mRNA in human placenta. 
Here, we have obtained direct evidence that the 
occurrence of two major species of P-45OARoM 
mRNA is mainly ascribed to alternative RNA pro- 
cessing using different poly(A) addition signals. It 
should be noted, however, that we have also ob- 
tained a unique cDNA clone; a portion of its 5 ‘-un- 
translated region (490 bp) is different from that 
reported by Harada [14] (Toda, K. et al., un- 
published). Although nothing is known of the 
transcription start site of the P-45OAROM gene, the 
existence of this unique cDNA clone may support 
Harada’s suggestion [14] to a certain extent. Fur- 
thermore, we have isolated another type of 
P-450AROM CDNA clone containing a 4 kbp insert 
and found that the nucleotide sequence of its pro- 
tein coding region is identical with that of pES-1 
cDNA, but its 3 ‘-noncoding region is markedly dif- 
ferent from that of pES-1 cDNA (Toda, K. et al., 
in preparation). This clone may correspond to the 
P-450AROM cDNA ClOneS having 4 kbp inserts 
recently isolated by McPhaul et al. [ 121 and by Cor- 
bin et al. [13]. These findings suggest hat the ex- 
pression of human placental P-45OARoM is more 
complicated than previously anticipated. It is, 
therefore, absolutely necessary to isolate and 
characterize genomic DNA(S) for P-450AROM in 
order to elucidate the regulation of its expression. 
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